DRAP registered medical device · imported

Mosovisc

Class D (high risk) · MDIR-0003713 · Bionta Pharma

✓ DRAP status Listed Valid until 24 Aug 2027
Screened against DRAP's published lists

DRAP REGISTERED MEDICAL DEVICE

Mosovisc (hyaluronic acid) [4ml Volume] is registered with DRAP under number MDIR-0003713 as a Class D (high risk) medical device, imported. The listed holder is Bionta Pharma. It is listed as valid until 24 Aug 2027.

Screening result

i
Imported device, registered with DRAP as Class D (high risk)
MDIR-0003713 · the class is taken from DRAP's list for this number
✓
Found in DRAP's published list
DRAP registered Class B/C/D list, 28 Aug 2025
✓
Listed valid until 24 Aug 2027
✓
Holder has a DRAP import licence on file
ELI-00367
DeviceMosovisc (hyaluronic acid) [4ml Volume]
ClassD
Listed holderBionta Pharma
Holder addressSuit No. A-10, Plot No. B-10, Gulshan-e-Iqbal Karachi
Manufacturing siteM/s Anika Therapeutics, Inc. 32 Wiggins Avenue, Bedford MA, 01730, USA.
Issued25 Aug 2022
Renewal date24 Aug 2027
LicenceELI-00367

Specifications

No supplier specifications yet.

Supplier of this device? Add specifications (free during launch)

Sign in or create a free account to add specifications.

Screened 20 Nov 2026, 01:14 (Pakistan time). A screening aid, not an official DRAP verification.

More devices from this holder

Other DRAP registrations and enlistments listed for the same company.

MDIR-0004493Cingal injection (Cross-linked sodium hyaluronate Triamcinolone hexacetonide) [4ml]Class D
MDIR-0004494Orthovisc (hyaluronic acid) [15mg/ml, 2ml Volume 15mg/ml, 1ml Volume]Class D

Corrections

Is something on this page wrong? Report a correction

Corrections are checked against the evidence before anything changes on this page.

Screen another number

Source: DRAP's published provisional lists. A screening aid, not an official DRAP verification; confirm with DRAP and the supplier's original documents.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9